Dr. Bjorn Oskarsson explains work of ALS researchers

Dr. Bjorn Oskarsson explains how research is advancing care for ALS and FTD. Bjorn Oskarsson, M.D., a Mayo Clinic neurologist, shares how breakthrough discoveries of toxic proteins linked to ALS and frontotemporal dementia (FTD) are helping researchers understand the diseases and advance work to care for those diagnosed. ____________________________________________ FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/ FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/ Mayo Clinic: https://mayocl.in/3tNMAdF Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic